<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="cfr.xsl"?>
<CFRGRANULE xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="CFRMergedXML.xsd">
  <FDSYS>
    <CFRTITLE>21</CFRTITLE>
    <CFRTITLETEXT>Food and Drugs</CFRTITLETEXT>
    <VOL>8</VOL>
    <DATE>1998-04-01</DATE>
    <ORIGINALDATE>1998-04-01</ORIGINALDATE>
    <COVERONLY>false</COVERONLY>
    <TITLE>Significant risk device determinations.</TITLE>
    <GRANULENUM>812.66</GRANULENUM>
    <HEADING>Section 812.66</HEADING>
    <ANCESTORS>
      <PARENT HEADING="" SEQ="4"/>
      <PARENT HEADING="" SEQ="3"/>
      <PARENT HEADING="SUBCHAPTER H" SEQ="2">MEDICAL DEVICES</PARENT>
      <PARENT HEADING="PART 812" SEQ="1">INVESTIGATIONAL DEVICE EXEMPTIONS</PARENT>
      <PARENT HEADING="Subpart D" SEQ="0">IRB Review and Approval</PARENT>
    </ANCESTORS>
  </FDSYS>
  <SECTION>
    <SECTNO>§ 812.66</SECTNO>
    <SUBJECT>Significant risk device determinations.</SUBJECT>
    <P>If an IRB determines that an investigation, presented for approval under § 812.2(b)(1)(ii), involves a significant risk device, it shall so notify the investigator and, where appropriate, the sponsor. A sponsor may not begin the investigation except as provided in § 812.30(a).</P>
    <CITA>[46 FR 8957, Jan. 27, 1981]</CITA>
  </SECTION>
</CFRGRANULE>
